Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 1
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Infections
Short report
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
Online download statistics by month:
Online download statistics by month: January 2022 to August 2023
Abstract
Full
Pdf
Jan 2022
651
630
206
Feb 2022
384
383
125
Mar 2022
270
268
71
Apr 2022
130
130
45
May 2022
115
111
57
Jun 2022
64
63
27
Jul 2022
68
67
15
Aug 2022
59
60
6
Sep 2022
80
76
28
Oct 2022
112
113
35
Nov 2022
51
47
21
Dec 2022
71
68
20
Jan 2023
65
62
15
Feb 2023
71
71
25
Mar 2023
29
30
15
Apr 2023
38
36
16
May 2023
15
14
15
Jun 2023
30
27
13
Jul 2023
24
22
13
Aug 2023
22
21
13
Total
2349
2299
781
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF